Toxys has developed ToxTracker and ToxTracker ACE, unique flow cytometry-based assays that identify various genotoxic and non-genotoxic properties of chemicals and pharmaceuticals that are associated with increased cancer risk. To accommodate in-house use of the assays Toxys now also offers them as a kit.
